Concepedia

Courtney E. Bakan

CE

Statistics

Publications

10

Citations

1.9K

H-Index

10

Active since

2009

Affiliations

The Ohio State University(Current)

Nationwide Children's Hospital

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Indiana University – Purdue University Indianapolis

Innate Pharma (France)

Courtney E. Bakan is an author at The Ohio State University specializing in oncology, immunotherapy, and multiple myeloma.

Publications per year

2009–2015

10

Publications

10

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody

Don M. Benson, Courtney E. Bakan, Anjali Mishra et al. · Blood · 2010 · 801 citations · Full text

Medicine, Immunology, Oncology +17

Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC

Shauna M. Collins, Courtney E. Bakan, Gina D. Swartzel et al. · Cancer Immunology Immunotherapy · 2013 · 293 citations

Life Sciences, Immunology, Oncology +11

A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma

Don M. Benson, Craig C. Hofmeister, Attaya Suvannasankha et al. · Blood · 2012 · 238 citations · Full text

Medicine, Immunology, Oncology +10

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect

Don M. Benson, Courtney E. Bakan, Shuhong Zhang et al. · Blood · 2011 · 201 citations · Full text

Life Sciences, Immunology, Oncology +16

The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity

Matthew A. Bill, James R. Fuchs, Chenglong Li et al. · Molecular Cancer · 2010 · 115 citations · Full text

Life Sciences, Immunology, Oncology +13

1–5 of 10